MRUS

Merus NV (MRUS)

Merus NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MRUS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	21 : 00	GlobeNewswire Inc.	Petosemtamab granted Breakthrough Therapy Designation by the U.S. FDA	NASDAQ:MRUS	Merus NV
2024/05/11	05 : 33	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/10	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2024/05/09	05 : 15	GlobeNewswire Inc.	Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update	NASDAQ:MRUS	Merus NV
2024/05/08	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRUS	Merus NV
2024/05/07	05 : 05	GlobeNewswire Inc.	Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC	NASDAQ:MRUS	Merus NV
2024/04/09	01 : 00	GlobeNewswire Inc.	Merus Presents Preclinical Data Demonstrating Efficacy of Zeno in Cancer Models with High NRG1 Expression at the AACR Annual Meeting 2024	NASDAQ:MRUS	Merus NV
2024/04/03	21 : 00	GlobeNewswire Inc.	Merus to Participate in a Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:MRUS	Merus NV
2024/03/06	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MRUS	Merus NV
2024/03/06	22 : 00	Business Wire	Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers	NASDAQ:MRUS	Merus NV
2024/03/06	06 : 30	GlobeNewswire Inc.	Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression	NASDAQ:MRUS	Merus NV
2024/03/04	22 : 00	GlobeNewswire Inc.	Merus to Participate in a Fireside Chat at the Leerink Partners Global Biopharma Conference	NASDAQ:MRUS	Merus NV
2024/02/29	06 : 55	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:MRUS	Merus NV
2024/02/29	06 : 15	GlobeNewswire Inc.	Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update	NASDAQ:MRUS	Merus NV
2024/02/15	06 : 05	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MRUS	Merus NV
2024/01/31	22 : 00	GlobeNewswire Inc.	Merus to Participate in Upcoming Investor Conferences	NASDAQ:MRUS	Merus NV
2023/12/21	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2023/12/19	07 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2023/12/16	09 : 29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRUS	Merus NV
2023/12/13	06 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2023/12/05	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MRUS	Merus NV
2023/12/03	10 : 40	GlobeNewswire Inc.	Merus Presents Interim Data on MCLA-129 at ESMO Asia Congress 2023	NASDAQ:MRUS	Merus NV
2023/12/02	00 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:MRUS	Merus NV